<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK541729" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK541729/" /><meta name="ncbi_pagename" content="Spinocerebellar Ataxia Type 37 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Spinocerebellar Ataxia Type 37 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Spinocerebellar Ataxia Type 37" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/05/30" /><meta name="citation_author" content="Antoni Matilla-Dueñas" /><meta name="citation_author" content="Victor Volpini" /><meta name="citation_pmid" content="31145571" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK541729/" /><meta name="citation_keywords" content="SCA37" /><meta name="citation_keywords" content="SCA37" /><meta name="citation_keywords" content="Disabled homolog 1" /><meta name="citation_keywords" content="DAB1" /><meta name="citation_keywords" content="Spinocerebellar Ataxia Type 37" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Spinocerebellar Ataxia Type 37" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Antoni Matilla-Dueñas" /><meta name="DC.Contributor" content="Victor Volpini" /><meta name="DC.Date" content="2019/05/30" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK541729/" /><meta name="description" content="Spinocerebellar ataxia type 37 (SCA37) is characterized by adult onset, dysarthria, slowly progressive gait and limb ataxia with severe dysmetria in the lower extremities, mild dysmetria in the upper extremities, dysphagia, and abnormal ocular movements (dysmetric vertical saccades, irregular and slow vertical smooth pursuit, slow vertical optokinetic nystagmus, and oscillopsia (visual disturbance in which objects appear to oscillate). In most individuals, the initial signs/symptoms include falls, dysarthria, or clumsiness followed by a complete cerebellar syndrome. A distinctive clinical feature is the presence of altered vertical eye movements in early stages of the disease, even preceding ataxia symptoms. Clinical progression is slow and affected individuals usually become wheelchair bound between ten and 33 years after disease onset." /><meta name="og:title" content="Spinocerebellar Ataxia Type 37" /><meta name="og:type" content="book" /><meta name="og:description" content="Spinocerebellar ataxia type 37 (SCA37) is characterized by adult onset, dysarthria, slowly progressive gait and limb ataxia with severe dysmetria in the lower extremities, mild dysmetria in the upper extremities, dysphagia, and abnormal ocular movements (dysmetric vertical saccades, irregular and slow vertical smooth pursuit, slow vertical optokinetic nystagmus, and oscillopsia (visual disturbance in which objects appear to oscillate). In most individuals, the initial signs/symptoms include falls, dysarthria, or clumsiness followed by a complete cerebellar syndrome. A distinctive clinical feature is the presence of altered vertical eye movements in early stages of the disease, even preceding ataxia symptoms. Clinical progression is slow and affected individuals usually become wheelchair bound between ten and 33 years after disease onset." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK541729/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sca37/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK541729/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BB6B7E040598100000000056F01D4.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK541729_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK541729_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca36/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca38/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK541729_"><span class="title" itemprop="name">Spinocerebellar Ataxia Type 37</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: SCA37</div><p class="contrib-group"><span itemprop="author">Antoni Matilla-Due&#x000f1;as</span>, BSc, MSc, PhD and <span itemprop="author">Victor Volpini</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK541729_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK541729_ai__"><div class="contrib half_rhythm"><span itemprop="author">Antoni Matilla-Due&#x000f1;as</span>, BSc, MSc, PhD<div class="affiliation small">Neurogenetics Unit<br />Neuroscience Department<br />Germans Trias i Pujol Research Institute (IGTP)<br />Badalona, Spain<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tac.ptgi@allitama" class="oemail">tac.ptgi@allitama</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Victor Volpini</span>, MD, PhD<div class="affiliation small">Molecular Genetics Center<br />Bellvitge Biomedical Research Institute (IDIBELL)<br />L'Hospitalet de Llobregat<br />Barcelona, Spain<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tac.llebidi@iniplovv" class="oemail">tac.llebidi@iniplovv</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 30, 2019</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sca37.Summary" itemprop="description"><h2 id="_sca37_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Spinocerebellar ataxia type 37 (SCA37) is characterized by adult onset, dysarthria, slowly progressive gait and limb ataxia with severe dysmetria in the lower extremities, mild dysmetria in the upper extremities, dysphagia, and abnormal ocular movements (dysmetric vertical saccades, irregular and slow vertical smooth pursuit, slow vertical optokinetic nystagmus, and oscillopsia (visual disturbance in which objects appear to oscillate). In most individuals, the initial signs/symptoms include falls, dysarthria, or clumsiness followed by a complete cerebellar syndrome. A distinctive clinical feature is the presence of altered vertical eye movements in early stages of the disease, even preceding ataxia symptoms. Clinical progression is slow and <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals usually become wheelchair bound between ten and 33 years after disease onset.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SCA37 is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> within <i>DAB1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons have 31-75 ATTTC repeats, flanked on both sides by polymorphic ATTTT repeats over 58 units.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Currently, no treatment reverts the course of the disease. Speech therapy to improve communication and ameliorate dysphagia; thickness modification of food and fluids to prevent aspiration; physical therapy to train balance; use of external devices (e.g., canes or walkers) when needed to avoid falls; occupational/behavioral therapy.</p><p><i>Surveillance:</i> Scale for the Assessment and Rating of Ataxia (SARA) score annually; electrooculographic tests may be performed every two years (cooperation required); brain MRI volumetry every two years.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SCA37 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. All individuals diagnosed to date with SCA37 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Each child of an individual with SCA37 is at a 50% risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> within <i>DAB1</i>. Prenatal testing for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if the ATTTC repeat insertion within <i>DAB1</i> has been identified in an affected family member.</p></div></div><div id="sca37.Diagnosis"><h2 id="_sca37_Diagnosis_">Diagnosis</h2><p>The phenotypic manifestations of spinocerebellar ataxia type 37 (SCA37) are not specific and no formal diagnostic criteria exist; thus, the diagnosis of SCA37 rests on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. However, if <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance is apparent, or if pure cerebellar ataxia with adult onset, initial dysarthria, and dysmetric vertical saccades are seen in a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case, SCA37 should be suspected.</p><div id="sca37.Suggestive_Findings"><h3>Suggestive Findings</h3><p>SCA37 <b>should be suspected</b> in individuals with the following clinical and imaging findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Dysarthria (scanning speech), often preceding other cerebellar signs</div></li><li class="half_rhythm"><div>Altered vertical and horizontal eye movements (e.g., dysmetric saccades, slow and irregular smooth pursuit, and slow optokinetic nystagmus). Abnormalities restricted to the vertical axis may be an initial and predominant feature.</div></li><li class="half_rhythm"><div>Progressive cerebellar gait ataxia (severe dysmetria in the lower extremities, mild in the upper extremities and trunk)</div></li><li class="half_rhythm"><div>Late eye movement abnormalities: nystagmus, oscillopsia, asymptomatic saccadic intrusions</div></li><li class="half_rhythm"><div>Late additional clinical findings: hand tremor, dysphagia</div></li><li class="half_rhythm"><div>Family history of similarly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li></ul><p><b>Imaging findings on brain MRI examination.</b> Initial vermis atrophy rapidly evolving to diffuse cerebellar atrophy with sparing of the brain stem [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>]</p></div><div id="sca37.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SCA37 <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive neurologic findings and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> ATTTC pentanucleotide repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> within an ATTTT repeat, in a 5' UTR <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> of <i>DAB1</i>, identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>] (see <a class="figpopup" href="/books/NBK541729/table/sca37.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figsca37Tmoleculargenetictestingusedi" rid-ob="figobsca37Tmoleculargenetictestingusedi">Table 1</a>).</p><div id="sca37.Allele_Sizes"><h4>Allele Sizes</h4><p><b>Normal alleles</b> have a repetitive ATTTT stretch of 7-400 units, which is not interrupted by ATTTC units, though 3% may be interrupted by AT-rich motifs; most (93%) bear &#x02264;30 ATTTT repeats [<a class="bk_pop" href="#sca37.REF.loureiro.2019.404">Loureiro et al 2019</a>].</p><p><b>Age-dependent penetrant alleles</b> have an <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> of 31-75 ATTTC repeats [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]. The ATTTC repeats are flanked by ATTTT repeats larger than 31 units on both sides. Both the ATTTT and ATTTC repeats appear to not be interrupted [<a class="bk_pop" href="#sca37.REF.loureiro.2019.404">Loureiro et al 2019</a>]. Alleles of this size or larger are associated with presumed development of SCA37, assuming a normal life span.</p><p>There are no known alleles of <b>incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a></b>.</p></div><div id="sca37.SingleGene_Testing"><h4>Single-Gene Testing</h4><p>Targeted analysis for the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> in <i>DAB1</i> should be performed by a <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a>-based assay, followed by determination of the fragment size and sequencing.</p><ul><li class="half_rhythm"><div>Long-range <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> followed by <a class="def" href="/books/n/gene/glossary/def-item/sanger-sequencing/">Sanger sequencing</a> has performed reliably to unequivocally identify and size the pathogenic ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>. For very large ATTTT/ATTTC alleles size could be estimated by automated electrophoresis.</div></li><li class="half_rhythm"><div>Repeat primed <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> (RP-PCR) may not be specific for pathogenic SCA37 ATTTC alleles and it is not recommended, due to the potential for false negative results.</div></li></ul><p>Note: The <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> is not detected by <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> analysis with <a class="def" href="/books/n/gene/glossary/def-item/next-generation-sequencing/">next-generation sequencing</a> because of the type and size of the repeat insert and its intronic noncoding localization within an Alu element in <i>DAB1.</i></p><div id="sca37.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Spinocerebellar Ataxia Type 37</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541729/table/sca37.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca37.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca37.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sca37.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_sca37.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_sca37.T.molecular_genetic_testing_used_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DAB1</i></td><td headers="hd_h_sca37.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup></td><td headers="hd_h_sca37.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sca37.TF.1.1"><p class="no_margin">See <a href="/books/NBK541729/#sca37.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sca37.TF.1.2"><p class="no_margin">See <a href="#sca37.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="sca37.TF.1.3"><p class="no_margin">Long-range <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> combined with <a class="def" href="/books/n/gene/glossary/def-item/sanger-sequencing/">Sanger sequencing</a> has been shown to be a reliable method to detect and characterize the ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> (see <a href="#sca37.SingleGene_Testing">Single-Gene Testing</a>). Repeat primed PCR (RP-PCR) may not be specific for pathogenic SCA37 ATTTC alleles and is not recommended, since it also has the potential for negative results.</p></div></dd><dt>4. </dt><dd><div id="sca37.TF.1.4"><p class="no_margin">Insertion of a variable number of ATTTC repeats flanked by two stretches of non-pathogenic polymorphic (ATTTT)<sub>n</sub> repeats in <i>DAB1</i> is the mutational mechanism in all families with SCA37 examined to date [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="sca37.Clinical_Characteristics"><h2 id="_sca37_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sca37.Clinical_Description"><h3>Clinical Description</h3><p>Spinocerebellar ataxia type 37 (SCA37) is characterized by a pure cerebellar ataxia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>]. A distinctive clinical feature is initial dysarthria and the presence of altered vertical eye movements in early stages of the disease [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</p><p><b>Age of onset and progression.</b> In four Spanish kindreds, onset reported was typically in the fifth decade (mean age of onset: 43.3 years &#x000b1; 9.9; range 25-64 years) and the mean disease duration was 49.5 years [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]. Clinical progression was slow and <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals usually became wheelchair bound between ten and 33 years after disease onset. A single individual with rapid progression has been reported to date. In 30 individuals with SCA37 of Portuguese descent, the mean age of onset was 35.7 years (range: 18-58 years) and the mean disease duration was 20 years (range: 3-54 years) [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>].</p><p><b>Presentation.</b> For most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> Spanish individuals, the initial symptoms included falls, dysarthria, and/or clumsiness, followed by a complete cerebellar syndrome. As a distinct clinical feature, abnormal vertical eye movements were detected in early stages of the disease [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]. Dysarthria was the first symptom identified in most of the affected individuals from the Portuguese kindreds, albeit with no reported data on vertical eye movements [<a class="bk_pop" href="#sca37.REF.coutinho.2013.746">Coutinho et al 2013</a>, <a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>].</p><p>Baseline MRI of the brain revealed general cerebellar atrophy with sparing of the brain stem in the individuals studied [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>]. Brain stem auditory evoked potentials yielded normal results. Electrocardiography, echocardiography, transcranial magnetic stimulation tests, and nerve conduction studies all were normal [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>].</p><p><b>Gait and limb ataxia</b></p><ul><li class="half_rhythm"><div>Severe dysmetria in the lower extremities</div></li><li class="half_rhythm"><div>Mild dysmetria in the upper extremities, mainly irregular fast alternating movements and dysmetria with the left hand, and mild trunk ataxia. Hand postural and action tremor variably appear with disease progression [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</div></li></ul><p><b>Dysphagia</b> is usually noted about five years after onset of SCA37.</p><p><b>Ocular problems</b></p><ul><li class="half_rhythm"><div>Abnormal ocular movements including dysmetric vertical saccades, irregular and slow vertical smooth pursuit, and slow vertical optokinetic nystagmus</div></li><li class="half_rhythm"><div>Individuals with long-standing disease showed these abnormalities also in the horizontal axis [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</div></li><li class="half_rhythm"><div>Nystagmus</div></li><li class="half_rhythm"><div>Oscillopsia (visual disturbance in which objects appear to oscillate)</div></li></ul><p>Individuals described with SCA37 to date do not have sensory deficits, extensor plantar reflexes, fasciculations, epileptic seizures, or cognitive impairment [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</p><p><b>Life span</b> is apparently not shortened.</p><p><b>Neuropathology.</b> Postmortem neuropathology of two individuals with SCA37 showed severe loss of Purkinje cells with abundant astrogliosis, empty baskets, occasional axonal spheroids, and hypertrophic fibers by phosphorylated neurofilament immunostaining in the cerebellar cortex [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]. The remaining cerebellar Purkinje neurons showed loss of calbindin immunoreactivity, aberrant dendrite arborization, nuclear pathology including lobulation, irregularity, and hyperchromatism, and multiple ubiquitinated perisomatic granules immunostained for DAB1. A subpopulation of Purkinje cells was found ectopically mispositioned within the cerebellar cortex. No significant neuropathologic alterations were identified in other brain regions, in accord with a pure cerebellar syndrome.</p></div><div id="sca37.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>A significant inverse correlation between ATTTC <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> size and age of onset is demonstrated in SCA37 [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>], with a gender-specific contribution of the ATTTC repeat size to the age of onset in male (r = -0.96; p&#x0003c;0.0001; n = 9), but not female transmissions (r = -0.09; p&#x0003c;0.75; n = 14) [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</p><p>Moreover, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females presented at a significantly younger age of onset (average = 40.4 years; average number of ATTTC repeats = 51.9) than males (average = 49.0 years; average number of ATTTC repeats = 52.7) (n = 23; p&#x0003c;0.021) [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</p><p>In six Portuguese kindreds, the mean age at onset reported was 33.76 (range 18-58) in 21 females and 40.33 (range 27-57) in nine <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> Portuguese males [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>]. In these, a sex difference in the correlation of onset age with size of the ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> was not noted, though only approximately 46% of that variability (from late adolescence to the early 60s) was accounted for by ATTTC repeat size [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>]. The average disease duration reported was 19.38 years (range 3-54) in 21 females and 21.44 years (range 5-40) in nine Portuguese males [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>].</p></div><div id="sca37.Penetrance"><h3>Penetrance</h3><p>Lifelong <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in SCA37 was 100% in all described families, but penetrance is age dependent [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</p></div><div id="sca37.Anticipation"><h3>Anticipation</h3><p>No evidence of <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> in the age at onset was identified in the three generations for which data are available from one large Spanish family [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>].</p><p>Intergenerational instability with increase in length of the ATTTC repeat (by 2-12 repeats) was reported in all seven paternal transmissions, but in only 9/16 (56%) of the maternal transmissions in Portuguese families [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>]. In contrast, smaller increments of 2-5 ATTTC repeat units were reported in four of six transmissions in the Spanish families [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]. In these families, none or smaller increments were observed when the mother was the transmitting parent. No ATTTC repeat contractions have been reported.</p><p>Thus, the (ATTTC)<sub>n</sub> <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> appears unstable, and even more so when the father is the transmitting parent.</p></div><div id="sca37.Prevalence"><h3>Prevalence</h3><p>To date, 66 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and seven asymptomatic individuals with the ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> within <i>DAB1</i> have been reported in ten kindreds from the south of the Iberian Peninsula [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>, <a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]. A common geographic origin in all ten families is suggestive of a <a class="def" href="/books/n/gene/glossary/def-item/founder-effect/">founder effect</a>. To date, no individuals with SCA37 from other geographic areas have been reported. The estimated prevalence of SCA37 has been reported in Portugal as 0.20/100,000 (95% CI: 0.13-0.31) [<a class="bk_pop" href="#sca37.REF.coutinho.2013.746">Coutinho et al 2013</a>].</p></div></div><div id="sca37.Genetically_Related_Allelic_Disord"><h2 id="_sca37_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>DAB1</i>.</p><p>Interstitial deletions encompassing <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region 1p32.1-1p32.3 including <i>DAB1</i> have been identified in individuals with microcephaly and multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies [<a class="bk_pop" href="#sca37.REF.kehrer.2015.2406">Kehrer et al 2015</a>].</p><p>Structural variants within the <i>DAB1</i> <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region have been associated with intellectual disability, autism, and <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features [<a class="bk_pop" href="#sca37.REF.mulatinho.2008.2284">Mulatinho et al 2008</a>, <a class="bk_pop" href="#sca37.REF.li.2013.226">Li et al 2013</a>].</p></div><div id="sca37.Differential_Diagnosis"><h2 id="_sca37_Differential_Diagnosis_">Differential Diagnosis</h2><p>The ataxic gait and the overall clinical picture in persons with spinocerebellar ataxia type 37 (SCA37) are indistinguishable from those seen in other adult-onset inherited or acquired pure cerebellar ataxias. Nevertheless, initial dysarthria and early altered vertical eye movements may be suggestive of SCA37, particularly when consistent within the same family. When the family history suggests <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance, all other autosomal dominant spinocerebellar ataxias (SCAs) need to be considered (see <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>). SCAs commonly reported to show a pure cerebellar <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> may be first investigated (e.g., SCA5, SCA6, SCA11, SCA26, SCA30, SCA31). SCA6 is the most common of these (see <a class="figpopup" href="/books/NBK541729/table/sca37.T.scas_with_a_pure_cerebellar_phen/?report=objectonly" target="object" rid-figpopup="figsca37Tscaswithapurecerebellarphen" rid-ob="figobsca37Tscaswithapurecerebellarphen">Table 2</a>). Other SCAs with a complex phenotype may present also as a pure cerebellar ataxia, particularly at an early stage. As with other hereditary diseases, examination of multiple <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relatives at different stages of evolution may be helpful for differential diagnosis.</p><div id="sca37.T.scas_with_a_pure_cerebellar_phen" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>SCAs with a Pure Cerebellar Phenotype to Consider in the Differential Diagnosis of SCA37</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541729/table/sca37.T.scas_with_a_pure_cerebellar_phen/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca37.T.scas_with_a_pure_cerebellar_phen_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comments</th></tr></thead><tbody><tr><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SCA5 (OMIM <a href="https://omim.org/entry/600224" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600224</a>)</td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPTBN2</i></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pure slowly progressive cerebellar syndrome</div></li><li class="half_rhythm"><div>Onset age range: 10-68 yrs; <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> &#x00026; infantile onset also reported</div></li><li class="half_rhythm"><div>Downbeat nystagmus, impaired smooth pursuit, &#x00026; gaze-evoked nystagmus</div></li></ul></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slower progression than in SCA37; individuals w/SCA5 remain ambulatory despite long disease duration.</td></tr><tr><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sca6/">SCA6</a></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CACNA1A</i></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Adult-onset slowly progressive ataxia</div></li><li class="half_rhythm"><div>Mild vibratory sensory loss</div></li><li class="half_rhythm"><div>Occasional dysphagia</div></li><li class="half_rhythm"><div>Horizontal &#x00026; vertical nystagmus</div></li><li class="half_rhythm"><div>Abnormal vestibuloocular reflex</div></li><li class="half_rhythm"><div>Rare oculomotor findings in presymptomatic individuals:</div><ul><li class="half_rhythm"><div>Low-amplitude horizontal gaze-evoked nystagmus</div></li><li class="half_rhythm"><div>Significantly &#x02193; eye velocity for upward saccades</div></li><li class="half_rhythm"><div>Abnormal frequency of square-wave jerks</div></li><li class="half_rhythm"><div>&#x02193; gain for pursuit tracking</div></li></ul></li></ul></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Positional vertigo, downbeat nystagmus, &#x00026; external ophthalmoplegia also reported in SCA6; not reported in SCA37.</div></li><li class="half_rhythm"><div>Individuals w/presymptomatic SCA37 may also have reduced gain for pursuit tracking, but in SCA37 saccade velocity is normal &#x00026; eye movement abnormalities initially affect the vertical axis.</div></li></ul></td></tr><tr><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sca11/">SCA11</a></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTBK2</i></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Relatively pure form of SCA</td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SCA26 (OMIM <a href="https://omim.org/entry/609306" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609306</a>)</td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EEF2</i></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pure SCA</div></li><li class="half_rhythm"><div>Irregular visual pursuit movements</div></li></ul></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dysmetric ocular saccades, slow optokinetic nystagmus, &#x00026; <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> not reported in SCA26</td></tr><tr><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SCA30 (OMIM <a href="https://omim.org/entry/613371" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613371</a>)</td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>1</sup></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Relatively pure, slowly progressive SCA</div></li><li class="half_rhythm"><div>Hypermetric saccades (typically horizontal &#x00026; into down gaze)</div></li><li class="half_rhythm"><div>Normal vestibuloocular reflex gain</div></li></ul></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype overlaps w/SCA37.</td></tr><tr><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SCA31 (OMIM <a href="https://omim.org/entry/117210" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">117210</a>)</td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BEAN1</i></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pure cerebellar syndrome</div></li><li class="half_rhythm"><div>Variable hearing loss of cochlear origin</div></li></ul></td><td headers="hd_h_sca37.T.scas_with_a_pure_cerebellar_phen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing loss of cochlear origin was reported in 1 individual w/SCA37 but did not appear related to SCA37.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">SCA = spinocerebellar ataxia</p></div></dd><dt>1. </dt><dd><div id="sca37.TF.2.1"><p class="no_margin">SCA30 was linked to 4q34.3-q35.1; the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and molecular defect remain unknown.</p></div></dd></dl></div></div></div><p>The most common SCAs are those caused by polyglutamine expansions (e.g., <a href="/books/n/gene/sca1/">SCA1</a>, <a href="/books/n/gene/sca2/">SCA2</a>, <a href="/books/n/gene/sca3/">SCA3/MJD</a>, <a href="/books/n/gene/sca6/">SCA6</a>, <a href="/books/n/gene/sca7/">SCA7</a>, <a href="/books/n/gene/sca17/">SCA17</a>, <a href="/books/n/gene/drpla/">DRPLA</a>); these should also be considered in the differential diagnosis. However, they usually begin before age 30 years, may progress more rapidly, show brain stem involvement on MRI, and may have a complex clinical presentation with distinctive features (as is the case with retinopathy in SCA7). In <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> individuals or sibships (particularly with <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents), Friedreich ataxia should not be neglected in the differential diagnosis of any SCA, as it is relatively common and may present on occasion with late onset and "atypical" forms.</p></div><div id="sca37.Management"><h2 id="_sca37_Management_">Management</h2><div id="sca37.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with spinocerebellar ataxia type 37 (SCA37), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Physical examination</div></li><li class="half_rhythm"><div>Neurologic assessment</div></li><li class="half_rhythm"><div>Assessment of the full range of symptoms associated with a progressive cerebellar syndrome. Among a range of clinical scoring systems that have been described [<a class="bk_pop" href="#sca37.REF.saute.2012.488">Saute et al 2012</a>], the Scale for the Assessment and Rating of Ataxia (SARA) [<a class="bk_pop" href="#sca37.REF.schmitzh_bsch.2006.1717">Schmitz-H&#x000fc;bsch et al 2006</a>] provides a reliable and consistent assessment of most of the clinical features and progression of SCA37.</div></li><li class="half_rhythm"><div>Electrooculographic tests may properly assess progression at the onset of disease.</div></li><li class="half_rhythm"><div>Specific assessment of the cerebellar cognitive affective syndrome may be considered.</div></li><li class="half_rhythm"><div>Brain MRI examination</div></li><li class="half_rhythm"><div>Consultation with speech, physical, behavioral, and occupational therapists</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sca37.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No curative treatment is available for individuals with SCA37. Palliative care includes the following:</p><ul><li class="half_rhythm"><div>Speech therapy to improve communication and ameliorate dysphagia</div></li><li class="half_rhythm"><div>Thickness modification of food and fluids to prevent aspiration</div></li><li class="half_rhythm"><div>Physical therapy to train balance</div></li><li class="half_rhythm"><div>Use of external devices (e.g., canes or walkers) when needed to avoid falls</div></li><li class="half_rhythm"><div>Occupational/behavior therapy</div></li></ul></div><div id="sca37.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>SARA score annually. Note: SARA may not detect disease progression for the first five to seven years.</div></li><li class="half_rhythm"><div>Electrooculographic tests may be performed every two years (cooperation is required).</div></li><li class="half_rhythm"><div>Brain MRI volumetry every two years</div></li></ul></div><div id="sca37.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sca37.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sca37.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sca37.Genetic_Counseling"><h2 id="_sca37_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sca37.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Spinocerebellar ataxia type 37 (SCA37) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="sca37.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>All individuals diagnosed to date with SCA37 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A proven <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> within the <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> ATTTT repeat in <i>DAB1</i> has not been reported to date.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The family history of an individual diagnosed with SCA37 may appear to be negative because of failure to recognize the disorder in family members, age-related <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to have the ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> within <i>DAB1</i>, the risk to the sibs of inheriting this variant is 50%.</div><ul><li class="half_rhythm"><div>An ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> may expand further in length, resulting in transmission of an allele with a larger ATTTC repeat. While possible, no evidence of <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> has been yet identified [<a class="bk_pop" href="#sca37.REF.serranomunuera.2013.764">Serrano-Munuera et al 2013</a>].</div></li><li class="half_rhythm"><div>In sibships with similar ATTTC repeat sizes, female sibs may present at a significantly younger age (see <a href="#sca37.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</div></li></ul></li><li class="half_rhythm"><div>However, sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still presumed to be at increased risk for SCA37 because of the possibility of age-related <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent (or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with SCA37 has a 50% chance of inheriting the ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> within <i>DAB1</i>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>, his or her family members may be at risk.</p></div><div id="sca37.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Predictive testing (i.e., testing of asymptomatic at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for at-risk relatives is possible once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div></li><li class="half_rhythm"><div>Potential consequences of such testing (including but not limited to socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li></ul><p><b>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals younger than age 18 years)</b></p><ul><li class="half_rhythm"><div>For asymptomatic minors at risk for adult-onset conditions for which early treatment would have no beneficial effect on disease morbidity and mortality, predictive genetic testing is considered inappropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</div></li><li class="half_rhythm"><div>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</div></li></ul><p>In a family with an established diagnosis of SCA37, it is appropriate to consider testing of symptomatic individuals regardless of age.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored. This scenario has not ever been reported in SCA37.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sca37.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the ATTTC repeat <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> within <i>DAB1</i> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="sca37.Resources"><h2 id="_sca37_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Associa&#x000e7;&#x000e3;o Portuguesa de Ataxias Heredit&#x000e1;rias (APAHE)</b></div><div>Rua 25 de Abril n.&#x000ba; 82</div><div>Castro Marim 8950-122</div><div>Portugal</div><div><b>Email:</b> apaheportugal@gmail.com</div><div><a href="https://www.apifarma.pt/cidadania/parcerias/associacoesdoentes/listaad/Paginas/Associa%C3%A7%C3%A3oPortuguesadeAtaxiasHeredit%C3%A1rias.aspx" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.apifarma.pt</a></div></li><li class="half_rhythm"><div><b>Ataxia UK</b></div><div>Lincoln House</div><div>1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> 0845 644 0606 (helpline); 020 7582 1444 (office); +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> helpline@ataxia.org.uk; office@ataxia.org.uk</div><div><a href="http://www.ataxia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org.uk</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22234/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spinocerebellar ataxia</a></div></li><li class="half_rhythm"><div><b>Spanish Ataxia Federation (FEDAES)</b></div><div>Spain</div><div><b>Phone:</b> 34 983 278 029; 34 985 097 152; 34 634 597 503</div><div><b>Email:</b> sede.valladolid@fedaes.org; sede.gijon@fedaes.org; sede.bilbao@fedaes.org</div><div><a href="http://www.fedaes.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fedaes.org</a></div></li><li class="half_rhythm"><div><b>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</b></div><div><i>Booklet providing information about Spinocerebellar Ataxia</i></div><div><a href="http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf</a></div></li><li class="half_rhythm"><div><b>CoRDS Registry</b></div><div>Sanford Research</div><div>2301 East 60th Street North</div><div>Sioux Falls SD 57104</div><div><b>Phone:</b> 605-312-6423</div><div><b>Email:</b> sanfordresearch@sanfordhealth.org</div><div><a href="http://www.sanfordresearch.org/SpecialPrograms/cords/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CoRDS Registry</a></div></li></ul></div><div id="sca37.Molecular_Genetics"><h2 id="_sca37_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sca37.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spinocerebellar Ataxia Type 37: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541729/table/sca37.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca37.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sca37.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sca37.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sca37.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sca37.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sca37.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sca37.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1600" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>DAB1</i></a></td><td headers="hd_b_sca37.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p32<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_sca37.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75553" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Disabled homolog 1</a></td><td headers="hd_b_sca37.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=DAB1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DAB1</a></td><td headers="hd_b_sca37.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=DAB1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">DAB1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sca37.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sca37.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spinocerebellar Ataxia Type 37 (<a href="/omim/603448,615945" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541729/table/sca37.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca37.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603448" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603448</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DAB ADAPTOR PROTEIN 1; DAB1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615945" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615945</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINOCEREBELLAR ATAXIA 37; SCA37</td></tr></tbody></table></div></div><div id="sca37.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Spinocerebellar ataxia type 37 (SCA37) is a repeat expansion disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> 5'UTR <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> of 31-75 ATTTC repeats, flanked on both sides by an ATTTT repeat tract with more than 58 units each, in <i>DAB1</i>. The complex repeat tract has an overall configuration (ATTTT)<sub>60-79</sub> (ATTTC)<sub>31-75</sub> (ATTTT)<sub>58-90</sub> [<a class="bk_pop" href="#sca37.REF.loureiro.2019.404">Loureiro et al 2019</a>]. Both the ATTTC and the ATTTT repeats are unstable. It is the (ATTTC)<sub>n</sub> insertion that is pathogenic, while pure (ATTTT)<sub>n</sub> stretches as large as 400 repeats are not [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>]. Normal alleles can be interrupted by AT-rich motifs, whereas the pathogenic alleles have a pure (ATTTC)<sub>n</sub> flanked by ATTTT repeats [<a class="bk_pop" href="#sca37.REF.loureiro.2019.404">Loureiro et al 2019</a>].</p><p>DAB1 functions downstream of reelin, a large glycoprotein secreted by neurons of the developing brain, in a signaling pathway that controls cell positioning in the developing brain and during adult neurogenesis. DAB1 docks to the intracellular part of the reelin very low-density lipoprotein receptor (VLDLR) and apoE receptor type 2 (ApoER2) and becomes tyrosine-phosphorylated following binding of reelin to neurons. In mice, pathogenic variants of Dab1 and Reelin generate highly similar phenotypes; <i>Dab1</i> mutation results in the scrambler and yotari mouse phenotypes [<a class="bk_pop" href="#sca37.REF.sheldon.1997.730">Sheldon et al 1997</a>]. Pathogenic variants in <i>VLDLR</i> cause <a href="/books/n/gene/vldlr-ch/"><i>VLDLR</i>-associated cerebellar hypoplasia</a> and pathogenic variants in <i>RELN</i> cause lissencephaly 2 (OMIM <a href="http://omim.org/entry/257320" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">257320</a>).</p><p><b>Mechanism of disease causation.</b> Several lines of evidence indicate that SCA37-related cerebellar neurodegeneration, like other repeat expansion disorders, occurs through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</p><p>The ATTTC <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> creates new putative XBP1 <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> binding motifs [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]. XBP1 has been implicated in Purkinje cell degeneration in <a href="/books/n/gene/sca17/">spinocerebellar ataxia type 17</a> (SCA17) [<a class="bk_pop" href="#sca37.REF.yang.2014.349">Yang et al 2014</a>]. Moreover, the ATTTC insertion causes RNA-switch and overexpression of specific RNA <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> (NCBI/GenBank accession: MK015668) in the SCA37 cerebellar cortex [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]. These cerebellar RNA isoforms include exons of <i>DAB1</i> that have been implicated in migration deficits of cerebellar Purkinje cells [<a class="bk_pop" href="#sca37.REF.yano.2010.848">Yano et al 2010</a>]. As in other spinocerebellar ataxias, such as <a href="/books/n/gene/sca1/">SCA1</a> [<a class="bk_pop" href="#sca37.REF.s_nchez.2016.4021">S&#x000e1;nchez et al 2016</a>], PI3K/AKT signaling has been shown to be altered in SCA37.</p><p><b><i>DAB1</i>-specific laboratory technical considerations.</b> SCA37 is caused by an <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> of 31 to 75 ATTTC repeats within a polymorphic ATTTT/AAAAT repeat in <i>DAB1</i>. Long-range <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> followed by <a class="def" href="/books/n/gene/glossary/def-item/sanger-sequencing/">Sanger sequencing</a> analysis has been used to reliably identify and size the pathologic ATTTC repeat insertion (see <a href="#sca37.Establishing_the_Diagnosis">Establishing the Diagnosis</a>). For very large ATTTT/ATTTC alleles, size could be estimated by automated electrophoresis.</p><p>Repeat primed <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> (RP-PCR) may not be specific for pathogenic SCA37 ATTTC alleles (since it would also show positive with the same amplification pattern of long ATTTT repeats) and has the potential for false negative and positive results; thus, it is not a recommended method.</p><p><b>Non-pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</b> (ATTTT)<sub>7&#x02013;400</sub></p><p><b>Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</b> [(ATTTT)<sub>60&#x02013;79</sub>(ATTTC)<sub>31&#x02013;75</sub>(ATTTT)<sub>58&#x02013;90</sub>]</p><div id="sca37.T.notable_dab1_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Notable <i>DAB1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK541729/table/sca37.T.notable_dab1_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca37.T.notable_dab1_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca37.T.notable_dab1_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_sca37.T.notable_dab1_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_sca37.T.notable_dab1_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment [Reference]</th></tr></thead><tbody><tr><td headers="hd_h_sca37.T.notable_dab1_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/MK015668" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MK015668</a><br /><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_021080.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_021080<wbr style="display:inline-block"></wbr>​.4</a></td><td headers="hd_h_sca37.T.notable_dab1_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(ATTTC)<sub>31-75</sub>&#x000a0;<sup>1</sup> in an <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> within <i>DAB1</i>&#x000a0;<sup>2</sup></td><td headers="hd_h_sca37.T.notable_dab1_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Located in a 5'UTR <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a>, flanked by (ATTTT)<sub>n</sub> on both sides [<a class="bk_pop" href="#sca37.REF.seixas.2017.87">Seixas et al 2017</a>, <a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>]</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="sca37.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="sca37.TF.3.2"><p class="no_margin">The (ATTTC)<sub>31-75</sub> <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> causes overexpression of an alternatively spliced transcript (NCBI/GenBank accession: MK015668) in the human cerebellum, the main site of SCA37 pathology [<a class="bk_pop" href="#sca37.REF.corraljuan.2018.1981">Corral-Juan et al 2018</a>].</p></div></dd></dl></div></div></div></div></div><div id="sca37.References"><h2 id="_sca37_References_">References</h2><div id="sca37.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.corraljuan.2018.1981">Corral-Juan M, Serrano-Munuera C, R&#x000e1;bano A, Cota-Gonz&#x000e1;lez D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, M&#x000e9;ndez-del-Barrio C, Jes&#x000fa;s S, Mir P, Volpini V, Alvarez-Ramo R, S&#x000e1;nchez I, Matilla-Due&#x000f1;as A. Clinical, genetic and neuropathological characterisation of spinocerebellar ataxia type 37. <span><span class="ref-journal">Brain. </span>2018;<span class="ref-vol">141</span>:1981–97.</span> [<a href="/pubmed/29939198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29939198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.coutinho.2013.746">Coutinho P, Ruano L, Loureiro JL, Cruz VT, Barros J, Tuna A, Barbot C, Guimar&#x000e3;es J, Alonso I, Silveira I, Sequeiros J, Marques Neves J, Serrano P, Silva MC. Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study. <span><span class="ref-journal">JAMA Neurol. </span>2013;<span class="ref-vol">70</span>:746–55.</span> [<a href="/pubmed/23609960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23609960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.kehrer.2015.2406">Kehrer M, Sch&#x000e4;ferhoff K, Bonin M, Jauch A, Bevot A, Tzschach A. Interstitial 1p32.1p32.3 deletion in a patient with multiple congenital anomalies. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:2406–10.</span> [<a href="/pubmed/26061568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26061568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.li.2013.226">Li J, Liu J, Zhao L, Ma Y, Jia M, Lu T, Ruan Y, Li Q, Yue W, Zhang D, Wang L. Association study between genes in Reelin signaling pathway and autism identifies DAB1 as a susceptibility gene in a Chinese Han population. <span><span class="ref-journal">Prog Neuropsychopharmacol Biol Psychiatry. </span>2013;<span class="ref-vol">44</span>:226–32.</span> [<a href="/pubmed/23333377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23333377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.loureiro.2019.404">Loureiro JR, Oliveira CL, Mota C, Castro AF, Costa C, Loureiro JL, Coutinho P, Martins S, Sequeiros J, Silveira I. Mutational mechanism for DAB1 (ATTTC)(n) insertion in SCA37: ATTTT repeat lengthening and nucleotide substitution. <span><span class="ref-journal">Hum Mutat. </span>2019;<span class="ref-vol">40</span>:404–12.</span> [<a href="/pubmed/30588707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30588707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.mulatinho.2008.2284">Mulatinho M, Llerena J, Leren TP, Rao PN, Quintero-Rivera F. Deletion (1)(p32.2-p32.3) detected by array-CGH in a patient with developmental delay/mental retardation, dysmorphic features and low cholesterol: a new microdeletion syndrome? <span><span class="ref-journal">Am J Med Genet A. </span>2008;<span class="ref-vol">146A</span>:2284–90.</span> [<a href="/pubmed/18680192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18680192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.s_nchez.2016.4021">S&#x000e1;nchez I, Balagu&#x000e9; E, Matilla-Due&#x000f1;as A. Ataxin-1 mediated regulation of the cerebellar proteome reveals a role in bioenergetics mechanisms which are altered in spinocerebellar ataxia type 1 (SCA1). <span><span class="ref-journal">Hum Mol Genet. </span>2016;<span class="ref-vol">25</span>:4021–40.</span> [<a href="/pubmed/27466200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27466200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.saute.2012.488">Saute JA, Donis KC, Serrano-Munuera C, Genis D, Ramirez LT, Mazzetti P, P&#x000e9;rez LV, Latorre P, Sequeiros J, Matilla-Due&#x000f1;as A, Jardim LB, et al.  Ataxia rating scales--psychometric profiles, natural history and their application in clinical trials. <span><span class="ref-journal">Cerebellum. </span>2012;<span class="ref-vol">11</span>:488–504.</span> [<a href="/pubmed/21964941" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21964941</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.schmitzh_bsch.2006.1717">Schmitz-H&#x000fc;bsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang JS, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Sch&#x000f6;ls L, Szymanski S, van de Warrenburg BP, D&#x000fc;rr A, Klockgether T, Fancellu R. Scale for the assessment and rating of ataxia: development of a new clinical scale. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">66</span>:1717–20.</span> [<a href="/pubmed/16769946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16769946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.seixas.2017.87">Seixas AI, Loureiro JR, Costa C, Ord&#x000f3;&#x000f1;ez-Ugalde A, Marcelino H, Oliveira CL, Loureiro JL, Dhingra A, Brand&#x000e3;o E, Cruz VT, Tim&#x000f3;teo A, Quint&#x000e1;ns B, Rouleau GA, Rizzu P, Carracedo &#x000c1;, Bessa J, Heutink P, Sequeiros J, Sobrido MJ, Coutinho P, Silveira I. A pentanucleotide ATTTC repeat insertion in the non-coding region of DAB1, mapping to SCA37, causes spinocerebellar ataxia. <span><span class="ref-journal">Am J Hum Genet. </span>2017;<span class="ref-vol">101</span>:87–103.</span> [<a href="/pmc/articles/PMC5501871/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5501871</span></a>] [<a href="/pubmed/28686858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28686858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.serranomunuera.2013.764">Serrano-Munuera C, Corral-Juan M, Stevanin G, San Nicol&#x000e1;s H, Roig C, Corral J, Campos B, de Jorge L, Morcillo-Su&#x000e1;rez C, Navarro A, Forlani S, Durr A, Kulisevsky J, Brice A, S&#x000e1;nchez I, Volpini V, Matilla-Due&#x000f1;as A. New subtype of spinocerebellar ataxia with altered vertical eye movements mapping to chromosome 1p32'. <span><span class="ref-journal">JAMA Neurology. </span>2013;<span class="ref-vol">70</span>:764–71.</span> [<a href="/pubmed/23700170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23700170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.sheldon.1997.730">Sheldon M, Rice DS, D'Arcangelo G, Yoneshima H, Nakajima K, Mikoshiba K, Howell BW, Cooper JA, Goldowitz D, Curran T. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. <span><span class="ref-journal">Nature. </span>1997;<span class="ref-vol">389</span>:730–3.</span> [<a href="/pubmed/9338784" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9338784</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.yang.2014.349">Yang S, Huang S, Gaertig MA, Li XJ, Li S. Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 Mice. <span><span class="ref-journal">Neuron. </span>2014;<span class="ref-vol">81</span>:349–65.</span> [<a href="/pmc/articles/PMC4863472/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4863472</span></a>] [<a href="/pubmed/24462098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24462098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca37.REF.yano.2010.848">Yano M, Hayakawa-Yano Y, Mele A, Darnell RB. Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. <span><span class="ref-journal">Neuron. </span>2010;<span class="ref-vol">66</span>:848–58.</span> [<a href="/pmc/articles/PMC2965850/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2965850</span></a>] [<a href="/pubmed/20620871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20620871</span></a>]</div></li></ul></div></div><div id="sca37.Chapter_Notes"><h2 id="_sca37_Chapter_Notes_">Chapter Notes</h2><div id="sca37.Author_Notes"><h3>Author Notes</h3><p>The authors have been experts on the genetic diagnosis of inherited ataxias since 1990. They have published more than 50 articles on ataxia research, identifying and describing a few novel spinocerebellar ataxia subtypes including SCA37.</p></div><div id="sca37.Acknowledgments"><h3>Acknowledgments</h3><p>Funding from the Spanish Health Institute Carlos III (ISCIII) is gratefully acknowledged (CPII/00029; FIS PI14/00136; FIS PI14/01159; FIS PI17/00534).</p></div><div id="sca37.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>30 May 2019 (sw) Review posted live</div></li><li class="half_rhythm"><div>14 August 2018 (amd) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK541729</span><span class="label">PMID: <a href="/pubmed/31145571" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31145571</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca36/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca38/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK541729&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK541729/?report=reader">PubReader</a></li><li><a href="/books/NBK541729/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK541729" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK541729" style="display:none" title="Cite this Page"><div class="bk_tt">Matilla-Dueñas A, Volpini V. Spinocerebellar Ataxia Type 37. 2019 May 30. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK541729/pdf/Bookshelf_NBK541729.pdf">PDF version of this page</a> (433K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sca37.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sca37.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sca37.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sca37.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sca37.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sca37.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sca37.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sca37.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sca37.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sca37.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sca37.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1600[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">DAB1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4777224" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4777224" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4777224" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4777224" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28686858" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia.</a><span class="source">[Am J Hum Genet. 2017]</span><div class="brieflinkpop offscreen_noflow">A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Seixas AI, Loureiro JR, Costa C, Ordóñez-Ugalde A, Marcelino H, Oliveira CL, Loureiro JL, Dhingra A, Brandão E, Cruz VT, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Hum Genet. 2017 Jul 6; 101(1):87-103. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29939198" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.</a><span class="source">[Brain. 2018]</span><div class="brieflinkpop offscreen_noflow">Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Corral-Juan M, Serrano-Munuera C, Rábano A, Cota-González D, Segarra-Roca A, Ispierto L, Cano-Orgaz AT, Adarmes AD, Méndez-Del-Barrio C, Jesús S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain. 2018 Jul 1; 141(7):1981-1997. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30588707" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutational mechanism for DAB1 (ATTTC)&lt;sub&gt;n&lt;/sub&gt; insertion in SCA37: ATTTT repeat lengthening and nucleotide substitution.</a><span class="source">[Hum Mutat. 2019]</span><div class="brieflinkpop offscreen_noflow">Mutational mechanism for DAB1 (ATTTC)&lt;sub&gt;n&lt;/sub&gt; insertion in SCA37: ATTTT repeat lengthening and nucleotide substitution.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Loureiro JR, Oliveira CL, Mota C, Castro AF, Costa C, Loureiro JL, Coutinho P, Martins S, Sequeiros J, Silveira I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mutat. 2019 Apr; 40(4):404-412. Epub 2019 Jan 9.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301354" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 10</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 10<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Matsuura T, Ashizawa T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301363" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Opal P, Ashizawa T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31145571" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31145571" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0412e6dd21425a25bc48a8">Spinocerebellar Ataxia Type 37 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Spinocerebellar Ataxia Type 37 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:54:46-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BB6B7E040598100000000056F01D4&amp;ncbi_session=CE8BB6B7E0412E51_1391SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK541729%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK541729&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK541729/&amp;ncbi_pagename=Spinocerebellar Ataxia Type 37 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BB6B7E0412E51_1391SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>